Coffee consumption and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2) Journal Article
| Authors: | Crous-Bou, M.; Du, M.; Gunter, M. J.; Setiawan, V. W.; Schouten, L. J.; Shu, X.; Wentzensen, N.; Bertrand, K. A.; Cook, L. S.; Friedenreich, C. M.; Gapstur, S. M.; Goodman, M. T.; Ibiebele, T. I.; La Vecchia, C.; Levi, F.; Liao, L. M.; Negri, E.; McCann, S. E.; O'Connell, K.; Palmer, J. R.; Patel, A. V.; Ponte, J.; Reynolds, P.; Sacerdote, C.; Sinha, R.; Spurdle, A. B.; Trabert, B.; van den Brandt, P. A.; Webb, P. M.; Petruzella, S.; Olson, S. H.; De Vivo, I.; on behalf of the Epidemiology of Endometrial Cancer Consortium (E2C2) |
| Article Title: | Coffee consumption and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2) |
| Abstract: | Background: Epidemiologic studies suggest that coffee consumption may be inversely associated with risk of endometrial cancer (EC), the most common gynecological malignancy in developed countries. Furthermore, coffee consumption may lower circulating concentrations of estrogen and insulin, hormones implicated in endometrial carcinogenesis. Antioxidants and other chemopreventive compounds in coffee may have anticarcinogenic effects. Based on available meta-analyses. the World Cancer Research Fund (WCRF) concluded that consumption of coffee probably protects against EC. Objectives: Our main aim was to examine the association between coffee consumption and EC risk by combining individual-level data in a pooled analysis. We also sought to evaluate potential effect modification by other risk factors for EC. Methods: We combined individual-level data from 19 epidemiologic studies (6 cohort, 13 case-control) of 12,159 EC cases and 27,479 controls from the Epidemiology of Endometrial Cancer Consortium (E2C2). Logistic regression was used to calculate ORs and their corresponding 95% Cls. All models were adjusted for potential confounders including age. race, BMI. smoking status, diabetes status, study design. and study site. Results: Coffee drinkers had a lower risk of EC than non-coffee drinkers (multiadjusted OR: 0.87; 95% CI: 0.79. 0.95). There was a dose-response relation between higher coffee consumption and lower risk of EC: compared with non-coffee drinkers, the adjusted pooled ORs for those who drank 1, 2-3, and >4 cups/d were 0.90 (95% CI: 0.82, 1.00). 0.86 (95% CI: 0.78, 0.95), and 0.76 (95% CI: 0.66, 0.87), respectively (P-trend < 0.001). The inverse association between coffee consumption and liC risk was stronger in participants with BMI > 25 kg/m(2). Conclusions: The results of the largest analysis to date pooling individual-level data further support the potentially beneficial health effects of coffee constunption in relation to EC, especially among females with higher BMI. |
| Keywords: | endometrial cancer; risk factors; health; epidemiology; association; components; prospective cohort; pooled analysis; nurses; premenopausal; c-peptide; coffee consumption; tea consumption; caffeine intake |
| Journal Title: | American Journal of Clinical Nutrition |
| Volume: | 116 |
| Issue: | 5 |
| ISSN: | 0002-9165 |
| Publisher: | American Society for Nutrition |
| Date Published: | 2022-11-01 |
| Start Page: | 1219 |
| End Page: | 1228 |
| Language: | English |
| ACCESSION: | WOS:000863549400001 |
| DOI: | 10.1093/ajcn/nqac229 |
| PROVIDER: | wos |
| PUBMED: | 36041172 |
| PMCID: | PMC9630862 |
| Notes: | Article -- Source: Wos |
Altmetric
Citation Impact
MSK Authors
-
232Olson -
24Petruzella -
69Du -
32O'Connell -
3Ponte
Related MSK Work